SG52841A1 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
SG52841A1
SG52841A1 SG1996010602A SG1996010602A SG52841A1 SG 52841 A1 SG52841 A1 SG 52841A1 SG 1996010602 A SG1996010602 A SG 1996010602A SG 1996010602 A SG1996010602 A SG 1996010602A SG 52841 A1 SG52841 A1 SG 52841A1
Authority
SG
Singapore
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
SG1996010602A
Other languages
English (en)
Inventor
George Petros Yiannikouros
Hans Richter
Henri Stalder
Ingrid Heinze-Kraus
Paul Hebeisen
Urs Weiss
Valeri Runtz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG52841A1 publication Critical patent/SG52841A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996010602A 1995-09-12 1996-09-11 Cephalosporin derivatives SG52841A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95114303 1995-09-12
EP95114304 1995-09-12

Publications (1)

Publication Number Publication Date
SG52841A1 true SG52841A1 (en) 1998-09-28

Family

ID=26138799

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996010602A SG52841A1 (en) 1995-09-12 1996-09-11 Cephalosporin derivatives

Country Status (15)

Country Link
US (1) US5804577A (zh)
JP (1) JPH09132578A (zh)
KR (1) KR100209839B1 (zh)
CN (1) CN1060778C (zh)
AU (1) AU709077B2 (zh)
CA (1) CA2184971A1 (zh)
CO (1) CO4750667A1 (zh)
CZ (1) CZ251896A3 (zh)
HU (1) HUP9602433A3 (zh)
IL (1) IL119215A0 (zh)
MA (1) MA23970A1 (zh)
NO (1) NO963805L (zh)
PL (1) PL316032A1 (zh)
SG (1) SG52841A1 (zh)
TR (1) TR199600715A2 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173979C (zh) * 1998-06-22 2004-11-03 巴斯利尔药物股份公司 丙烯基头孢茵素衍生物
EP1006689B1 (en) * 1998-11-30 2008-02-06 Matsushita Electric Industries Co., Ltd. Packet retransmission control using priority information
ATE308549T1 (de) * 2000-08-14 2005-11-15 Basilea Pharmaceutica Ag Herstellung von n-geschützten-3-pyrrolidin-lactam substituierten phosphonium salzen
KR101128065B1 (ko) * 2004-05-26 2012-04-12 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물
EP1808432B1 (en) 2004-10-26 2010-02-24 Eisai R&D Management Co., Ltd. Amorphous form of cinnamide compound
EP1950211A4 (en) * 2005-11-18 2011-08-31 Eisai R&D Man Co Ltd PROCESS FOR PREPARING A CINEMA ACID AMID DERIVATIVE
WO2007058304A1 (ja) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. シンナミド化合物の塩またはそれらの溶媒和物
TWI378091B (en) * 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
JPWO2007135970A1 (ja) * 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環系−シンナミド誘導体
JPWO2007135969A1 (ja) * 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ウレア系−シンナミド誘導体
US20080207900A1 (en) * 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
JPWO2008140111A1 (ja) * 2007-05-16 2010-08-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 シンナミド誘導体のワンポット製造方法
MX2010002098A (es) * 2007-08-31 2010-03-30 Eisai R&D Man Co Ltd Compuesto policiclico.
US7935815B2 (en) * 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
WO2009096349A1 (ja) * 2008-01-28 2009-08-06 Eisai R & D Management Co., Ltd. 結晶性のシンナミド化合物またはその塩

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
EP0620225B1 (en) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Cephalosporin derivatives
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics

Also Published As

Publication number Publication date
IL119215A0 (en) 1996-12-05
CO4750667A1 (es) 1999-03-31
AU6550696A (en) 1997-03-20
AU709077B2 (en) 1999-08-19
CA2184971A1 (en) 1997-03-13
HUP9602433A2 (en) 1997-05-28
CN1150950A (zh) 1997-06-04
NO963805D0 (no) 1996-09-11
PL316032A1 (en) 1997-03-17
JPH09132578A (ja) 1997-05-20
US5804577A (en) 1998-09-08
KR100209839B1 (ko) 1999-07-15
KR970015593A (ko) 1997-04-28
NO963805L (no) 1997-03-13
CZ251896A3 (en) 1997-04-16
TR199600715A2 (tr) 1997-03-21
MA23970A1 (fr) 1997-04-01
MX9604017A (es) 1997-07-31
CN1060778C (zh) 2001-01-17
HU9602433D0 (en) 1996-10-28
HUP9602433A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
SG64953A1 (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
HUP9602433A3 (en) Cephalosporin derivatives
HUP9600107A2 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
EP0727426A3 (en) Cephalosporin derivatives
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
AU3039895A (en) Cephalosporin derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
HUP9903621A3 (en) Cephalosporin derivatives
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
HK1011013A1 (en) Fluorobenzylether derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
AU1278197A (en) Cephalosporin derivatives
PL324892A1 (en) Aza-antracyclinone derivatives
GR3036344T3 (en) 4-mercapto-benzoylguanidine derivatives
GB9525697D0 (en) Cephem derivatives